| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Yang S et al. | 1 alpha, 25-Dihydroxyvitamin D3 and 19-nor-1 alpha, 25-dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo. | 1993 | Biochim. Biophys. Acta | pmid:8251528 |
| Takahashi F et al. | A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. | 1997 | Am. J. Kidney Dis. | pmid:9214408 |
| Martin KJ et al. | 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. | 1998 | J. Am. Soc. Nephrol. | pmid:9697664 |
| McIntyre CW et al. | Effects of new analogues of vitamin D on bone cells: implications for treatment of uremic bone disease. | 1999 | Kidney Int. | pmid:9987074 |
| Finch JL et al. | Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. | 1999 | J. Am. Soc. Nephrol. | pmid:10232683 |
| Stephens D et al. | A statistical experimental approach to cosolvent formulation of a water-insoluble drug. | 1999 | Drug Dev Ind Pharm | pmid:10434141 |
| Zager RA | Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack. | 1999 | Am. J. Pathol. | pmid:10362817 |
| Goldenberg MM | Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. | 1999 | Clin Ther | pmid:10321413 |
| Balint E et al. | Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro. | 2000 | Am. J. Kidney Dis. | pmid:11007682 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.